… Objective/Rationale: Viruses need to keep cells alive during the course of their infection. We … cells dying. This viral RNA interacts with an important component of the mitochondrion, protecting the cell from … death. We propose to ask whether this viral RNA can prevent neurodegeneration in models of Parkinson’s disease. …

… about disease and developing new treatments takes the right tools. The Michael J. Fox Foundation works with leading … to explore Parkinson's and create therapies. A recent commentary piece in Biochemical Journal profiles "the latest … or make sure your profile is up to date. Maggie Kuhl Vice President Patient Engagement …

… for Clinical Development Supplement Promising Outcomes of Original Grant: A newly developed glyoxylate series of metalloporphyrin compounds designed to penetrate the blood brain barrier have shown high … evaluation of their bioavailability and efficacy in pre-clinical models. Our results identified several …

… Editor's Note: For more Foundation news and research updates, … newsletter. The Michael J. Fox Foundation (MJFF) takes a comprehensive approach to Parkinson's disease. We work to …

… Study Rationale: Currently there is no preventive treatment for Parkinson’s disease. Our recent … are associated with slower progression of parkinsonism symptoms in older adults. This present study will further … a huge public health impact in preventing or delaying these common symptoms among older adults. Next Steps for …

… Denise Coley, second from left, receives a 2024 Woman of the Year Award from her … therapists and social workers. Soon, we became known as Team Coley: Parkinson’s Advocates. Our goal is to … and research to under-engaged groups within the Parkinson’s community, empower them to become advocates and help them …